XML 33 R24.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stockholders' (Deficit) Equity (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Stockholders' (Deficit) Equity |
Schedule of changes in common stock warrant liabilities | The following is a roll-forward of the Common Stock Warrant Liability from December 31, 2023 to June 30, 2024:
​ | ​ | ​
Warrant liability at December 31, 2023 |  | 13,680,000
Exercise of 60,000 warrants – January 2, 2024 |  | (684,000)
Change in fair value of warrant liabilities |  | (6,698,692)
Warrant liability at March 31, 2024 |  | 6,297,308
Change in fair value of warrant liabilities | ​ | (4,062,308)
Warrant liability at June 30, 2024 |  | 2,235,000
​
Schedule of common stock warrants outstanding | As of June 30, 2024, the Company had the following common stock warrants outstanding:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Outstanding |  | ​ |  |  |  | Outstanding |  | Exercise |  | ​
​ | ​ | ​ | ​ | December 31, | ​ | ​ | ​ | Exercised or | ​ | June 30, | ​ | price per | ​ | Expiration
​ | ​ | Classification | ​ | 2023 | ​ | Granted | ​ | Expired | ​ | 2024 | ​ | share | ​ | date
IPO Warrants |  | Equity |  | 2,400 |  | — |  | — |  | 2,400 | ​ | $ | 7.50 | ​ | January 29, 2026
Canaccord Warrants |  | Liability |  | 1,200,000 |  | — |  | (60,000) |  | 1,140,000 | ​ | $ | 9.00 | ​ | November 2, 2028
​
Summary of changes in derivative liability | The following is a roll-forward of the ELOC derivative liability from date of execution to June 30, 2024: ​
​ | ​ | ​
Fair value at April 25, 2024 |  | 1,697,500
Settlements and changes in fair value of ELOC derivative liability |  | (1,192,500)
Fair value at June 30, 2024 |  | 505,000
​

X
- Definition Tabular disclosure of changes in common stock warrant liabilities. + References No definition available. + Details
Name: | anvs_ScheduleOfChangesInCommonStockWarrantLiabilitiesTableTextBlock
Namespace Prefix: | anvs_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative liabilities at fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration